Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 14 of 14 for “"HIV persistence"”.

  1. Mechanisms for HIV persistence during effective treatment

    … antiretroviral therapy (ART) that suppresses HIV replication to below the limit-of-quantification of commercial assays, small numbers of virions can often still be detected in the plasma, termed residual viremia (RV). The cells producing infectious RV must be eliminated to cure the infection. …

    washington Repository record for Mechanisms for HIV persistence during effective treatment (opens in a new tab)

  2. Enhancement of Hiv Persistence By Adipose Tissue

    A major challenge for HIV eradication is the persistence of cellular and anatomic viral reservoirs. The primary cellular reservoirs for HIV, memory CD4 T cells and macrophages, traffic into various tissues where most viral replication occurs, or in the case of virally-suppressed …

    uthsc Repository record for Enhancement of Hiv Persistence By Adipose Tissue (opens in a new tab)

  3. CD73: A Key Player in HIV Persistence

    Replication of human immunodeficiency virus (HIV) is suppressed to undetectable levels by effective antiretroviral therapy (ART). However, current therapeutic regimens fail to completely eradicate HIV due to the persistence of latently-infected cells. These viral reservoirs are established very …

    fu-berlin Repository record for CD73: A Key Player in HIV Persistence (opens in a new tab)

  4. IMPACT OF ANTIRETROVIRAL TREATMENT ON HIV-1 LATENT RESERVOIRS AND ONGOING VIRAL REPLICATION

    The human immunodeficiency virus (HIV), the causative agent of acquired immunodeficiency syndrome (AIDS), remains a significant public health challenge. In Belgium, 1 to 2 new cases are diagnosed daily. Since the introduction of antiretroviral therapy (ART) in 1996, the life expectancy and quality …

    liege Repository record for IMPACT OF ANTIRETROVIRAL TREATMENT ON HIV-1 LATENT RESERVOIRS AND ONGOING VIRAL REPLICATION (opens in a new tab) Restricted access

  5. Application of engineered T cell receptors to investigate the failure of cytotoxic T lymphocytes to eliminate the HIV reservoir

    <p>HIV establishes a reservoir comprising long lived, latently infected CD4+ T cells and monocytic cells early during primary infection. This population represents a major barrier to an HIV cure. This thesis aimed to investigate the role of the immunological synapse in the failure of cytotoxic T …

    oxford Repository record for Application of engineered T cell receptors to investigate the failure of cytotoxic T lymphocytes to eliminate the HIV reservoir (opens in a new tab)

  6. THE EFFECTS OF HIV INFECTION ON THE EXPRESSION OF THE DRUG EFFLUX PROTEINS P-GLYCOPROTEIN AND BREAST CANCER RESISTANCE PROTEIN IN A HUMAN INTESTINE MODEL

    … gastrointestinal (GI) tissues may contribute to HIV persistence within reservoirs despite effective therapy. We hypothesize that HIV infection induces an upregulation of drug efflux pumps P-glycoprotein and Breast Cancer Resistance Protein (BCRP) within GI lymphocytes which may limit …

    ku Repository record for THE EFFECTS OF HIV INFECTION ON THE EXPRESSION OF THE DRUG EFFLUX PROTEINS P-GLYCOPROTEIN AND BREAST CANCER RESISTANCE PROTEIN IN A HUMAN INTESTINE MODEL (opens in a new tab)

  7. The effects of HIV-1 infection, viral particle production, and proviral integration site on CD4+ T cell proliferation

    The latent reservoir of HIV is the major barrier to cure. Stimulation of latently-infected T cells results in the nuclear translocation of key transcription factors that are required for both cellular activation and reactivation of the latent provirus. These two transcriptional programs result in …

    jhu Repository record for The effects of HIV-1 infection, viral particle production, and proviral integration site on CD4+ T cell proliferation (opens in a new tab)

  8. Functional Expression and Regulation of Drug Efflux Transporters and Drug Metabolic Enzymes in the Testis and Circulating T-cells: Relevance to HIV-1 Pharmacotherapy

    … advances in human immunodeficiency virus (HIV) pharmacotherapy with the implementation of combination antiretroviral therapy (ART), HIV persistence in cellular reservoirs and tissue sanctuary sites is a major obstacle preventing the eradication of the virus. Suboptimal antiretroviral drug …

    toronto-retro Repository record for Functional Expression and Regulation of Drug Efflux Transporters and Drug Metabolic Enzymes in the Testis and Circulating T-cells: Relevance to HIV-1 Pharmacotherapy (opens in a new tab)

  9. Targeted Nanocarriers for HIV Therapy

    … therapy (HAART) can successfully suppress HIV-1 replication in plasma to undetectable levels, but is not capable of eradicating the virus from long-live cellular reservoirs. The latent reservoir for HIV-1 is sustained by the longevity and proliferative capacity of resting CD4 T cells …

    washington Repository record for Targeted Nanocarriers for HIV Therapy (opens in a new tab)

  10. PERSISTENT NEUROPATHOGENESIS AND THE ROLE OF MYELOID EXTRACELLULAR VESICLES IN A SHIV.D/MACAQUE MODEL OF HUMAN IMMUNODEFICIENCY VIRUS

    … of people with human immunodeficiency virus (HIV)(PWH), approximately half of PWH on suppressive ART will experience HIV-associated neurological dysfunction. While ART has decreased the incidence of severe neurological disease and dementia in PWH, the incidence of milder neurological and …

    temple Repository record for PERSISTENT NEUROPATHOGENESIS AND THE ROLE OF MYELOID EXTRACELLULAR VESICLES IN A SHIV.D/MACAQUE MODEL OF HUMAN IMMUNODEFICIENCY VIRUS (opens in a new tab)

  11. THE ROLE OF CD4+ T MEMORY SUBSETS IN HIV INFECTION: IMMUNE RESPONSE IN PEOPLE WITH HIV AND LATENCY ESTABLISHMENT

    … In the context of human immunodeficiency virus (HIV), CD4+ TSCM, serve as target of infection as well as reservoir, sustaining long-lived, self-renewing pools of latently infected cells despite antiretroviral therapy (ART). Thus, TSCM are central to both protective immunity and the persistence of …

    milano Repository record for THE ROLE OF CD4+ T MEMORY SUBSETS IN HIV INFECTION: IMMUNE RESPONSE IN PEOPLE WITH HIV AND LATENCY ESTABLISHMENT (opens in a new tab)

  12. Pharmacologic Stratagies Toward Curing HIV-1 Infection: Identification and Evaluation of Small-Molecule HIV-1 Latency Reversing Agents

    … antiretroviral therapy (HAART) can reduce plasma HIV-1 levels in infected individuals to below the limit of detection of clinical assays (<50 copies HIV-1 RNA per ml of plasma). Despite this, antiretroviral therapy (ART) is not curative as HIV-1 establishes a state of latent infection in resting …

    jhu Repository record for Pharmacologic Stratagies Toward Curing HIV-1 Infection: Identification and Evaluation of Small-Molecule HIV-1 Latency Reversing Agents (opens in a new tab)

  13. EVOLVED PLATFORMS FOR VIRAL OUTGROWTH AND MOLECULAR CHARACTERIZATION OF HIV WITHIN TISSUE RESERVOIRS

    HIV persists during long-term, effective antiretroviral therapy within reservoir cells. While CD4-positive lymphocytes are accepted as bona fide reservoirs, the contribution of other HIV-susceptible cell types to viral persistence remains unknown. ART therapy is a lifelong commitment for those with …

    cornell Repository record for EVOLVED PLATFORMS FOR VIRAL OUTGROWTH AND MOLECULAR CHARACTERIZATION OF HIV WITHIN TISSUE RESERVOIRS (opens in a new tab)

  14. ANALYSIS OF VIRAL RESERVOIRS IN CHRONICALLY SIV-INFECTED SOOTY MANGABEYS TREATED WITH COMBINATION ANTIRETROVIRAL THERAPY (CART)

    Background: Human Immunodeficiency Virus (HIV), the causative pathogen of Acquired Immunodeficiency Syndrome (AIDS), continues to be a major global public health issue. Although, potent antiretroviral therapy (ART) has dramatically reduced the morbidity and mortality in HIV-infected individuals, …

    milano Repository record for ANALYSIS OF VIRAL RESERVOIRS IN CHRONICALLY SIV-INFECTED SOOTY MANGABEYS TREATED WITH COMBINATION ANTIRETROVIRAL THERAPY (CART) (opens in a new tab)